Company intelligence / Profile preview
Matins Pharma
Bedminster, New Jersey, United Statesmatinspharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Matins Pharma is a clinical-stage biopharmaceutical company dedicated to developing transformative treatments for metabolic disorders, with a primary focus on Type 2 diabetes and non-alcoholic steatohepatitis (NASH). The company's lead program, MT-3011, is a liver-selective glucokinase activator (GKA) that was originally discovered by Pfizer. By specifically targeting glucokinase in the liver, MT-3011 aims to lower blood glucose levels and reduce hepatic fat accumulation while avoiding the hypoglycemia and hypertriglyceridemia risks associated with systemic GKAs. Matins Pharma is currently advancing its clinical pipeline to address significant unmet needs in the global metabolic health market.
- Therapeutic areas
- EndocrinologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Beyond the preview
Go deeper on Matins Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Matins Pharma.